US Raises Concerns about Illnesses Tied to Synthetic Pot

U.S. health officials are urging states to regulate marijuana oil extracts after investigating a rash of illnesses tied to the products in Utah.
In a report released Thursday, the Centers for Disease Control and Prevention found that synthetic products falsely labeled as cannabidiol, or CBD, sickened as many as 52 people from October through January.
The CDC urged states to set up regulatory and control systems "to minimize the risk for recurrences of this emerging public health threat."
CBD is derived from cannabis but is designed not to produce a high. Users say it provides relief from pain and can fight seizures.
This year, Utah passed a new law that supporters say will prevent the illnesses from happening again.
The oil had previously been in a legal gray area. It's been legal for people with epilepsy in Utah since 2014, but there is no regulatory system to oversee the oil's safety.
Bottles labeled as CBD have edged their way into Utah smoke shops and health food stores in recent years. Sales to the general public have been technically illegal but largely ignored by authorities.
"It's been a little bit of a don't ask, don't tell kind of a business," said Jack Wilbur, a spokesman for the Utah Department of Agriculture and Food.
There's been no way for consumers to know if products are what they claim to be, he said.
The CDC report this week found that more than half of the 52 possible cases either tested positive for a synthetic compound called 4-CCB or reporting using a product called Yolo CBD Oil, samples of which contained the synthetic instead of authentic CBD. Efforts to determine what company manufactures Yolo CBD Oil were not successful.
Lt. Ryan Van Fleet, head of major crimes in the State Bureau of Investigation, said no charges were filed or stores were raided based on the illnesses.
This year, the state Legislature passed reforms legalizing CBD for the general public and creating a system to register and test products for quality.
"It does make it legal for people to purchase it," said state Sen. Evan Vickers, a Republican pharmacist who sponsored the new law. "We just want to make sure that if they are going to purchase it that it is safe."
Vickers said the new law should prevent people from taking synthetics falsely marketed as CBD.
Utah is currently writing regulations to implement the law, Wilbur said. He expected rules to be finalized by the end of the year
Nationally, 30 states have legalized some form of medical marijuana and 16 others have laws on CBD-specific medical treatment, according to the National Conference of State Legislatures. But rules for dispensing and manufacturing CBD vary widely.
Marijuana activists have said Utah's new law is not enough. They're pushing a ballot initiative that will legalize medical marijuana beyond the narrow limits approved by state lawmakers this year, which allows use only for terminally ill patients.
"These people having problems with CBD oil is 100 percent a side effect of prohibition," said Angela Bacca, a media strategist working with advocacy group TRUCE Utah.
Bacca says keeping most forms of cannabis illegal makes people desperate for treatment they can only find through unregulated products.
The Utah lieutenant governor's office will certify by June 1 whether the initiative can reach the ballot.
Opponents including Vickers and the Republican Gov. Gay Herbert have said the proposal is full of loopholes that could make marijuana too easy to obtain.
Looking for chemical products? Let suppliers reach out to you!
A Bright Prospect for PC
2026-07-11
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
VIV Health & Nutrition Asia 2026 Brings Together Innovation and Business Across the Animal Feed and Health Industry
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
Biden decided to raise tariffs on Chinese goods, US soybeans maybe face tariff adjustment challenges
-
U.S. agricultural supplies distributor CHS and West Central Ag Services sign merger intent
-
PPG launches strategic review: intends to sell North American architectural coatings business with annual revenue of nearly US$1.8 billion
-
The US chemical industry has had a tough profit season
-
Warm winter impact energy market US coal prices fell rapidly
-
The United States has released its annual update on Salmonella surveillance and testing at poultry producers across the country
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Four Foods that can Protect Your Heart Health
Recommend Reading
-
BASF’s Price Increase Shows Pharma Excipients Are Still Exposed to Chemical Cost Pressure
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Lilly’s Indiana Investment Puts API Capacity at the Center of Obesity Drug Competition
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
Premium Global Chemical Sourcing Requests (6-11 Sep 2025)
-
Sulfate Ammonium Market Continues to Rise (10.9-10.16)
-
Supply-Demand Mismatch: Acrylonitrile Market Stagnant and Relatively Weak in May
-
Spread Widens as Shandong Cyclohexanone Market Prices Continue to Decline in May